Kamada (KMDA) Receivables - Other (2012 - 2026)

Kamada (KMDA) posted quarterly Receivables - Other of $4.1 million for Q1 2026, down 31.25% year-on-year from $6.0 million in Q1 2025, and down 26.87% on a QoQ basis from $5.7 million in Q4 2025.

Kamada (KMDA) Receivables - Other (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Receivables - Other for 15 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Receivables - Other fell 31.25% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 31.25% YoY) and the FY2025 annual result came in at $5.7 million, up 1.98% from the prior year.
  • Receivables - Other retreated to $4.1 million in Q1 2026 per KMDA's latest filing, from $5.7 million in the prior quarter.
  • Over the last five years, Receivables - Other for KMDA reached as high as $7.9 million in Q1 2022 and fell as low as $3603.0 in Q1 2023.
  • A 5-year average of $4.2 million and a median of $4.7 million in 2025 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2023 — Receivables - Other slumped 99.95% — and 2024, when it surged 177835.05%.
  • Year by year, Receivables - Other stood at $544000.0 in 2022, then jumped by 996.51% to $6.0 million in 2023, then decreased by 7.02% to $5.5 million in 2024, then advanced by 1.98% to $5.7 million in 2025, then fell by 26.87% to $4.1 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods registered $4.1 million, $5.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.14 Mn
Mar 31, 2026 4.14 Mn
Dec 31, 2025 5.66 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 3.95 Mn
Sep 30, 2025 3.95 Mn
Jun 30, 2025 4.70 Mn
Jun 30, 2025 4.70 Mn
Mar 31, 2025 6.02 Mn
Mar 31, 2025 6.02 Mn
Dec 31, 2024 5.55 Mn
Dec 31, 2024 5.55 Mn
Sep 30, 2024 4.56 Mn
Sep 30, 2024 4.56 Mn
Jun 30, 2024 4.94 Mn
Jun 30, 2024 4.94 Mn
Mar 31, 2024 6.41 Mn
Mar 31, 2024 6.41 Mn
Dec 31, 2023 5.97 Mn
Dec 31, 2023 5.97 Mn